30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Bohen Sean

Insider profile

Performance

Overall performance
3.8

Performance over holding periods
3.8
30 days 90 days 120 days
Average return 27% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Bohen Sean's trades of Olema Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-12-11 2024-12-11 PrS Proposed sale
80,911
164.37
US$860,230
80,911 164.37 US$860,230
2024-12-11 2024-12-11 S Sale
4,206 -29.0%
433.29
US$2,482,341
4,206 -29.0% 433.29 US$2,482,341
2024-12-11 2024-12-11 S Sale
45,346 +8.0%
207.38
US$3,053,686
45,346 +8.0% 207.38 US$3,053,686
2024-12-11 2024-12-10 S Sale
52,328 -14.9%
9.37
US$490,313
52,328 -14.9% 9.37 US$490,313
2024-12-10 2024-12-10 PrS Proposed sale
52,328
9.37
US$490,241
52,328 9.37 US$490,241
2023-11-22 2023-11-22 PrS Proposed sale
27,932
13.90
US$388,117
27,932 13.90 US$388,117
2023-11-22 2023-11-22 S Sale
27,932 -16.2%
13.90
US$388,255
27,932 -16.2% 13.90 US$388,255
2023-11-22 2023-11-21 S Sale
2,602 -1.5%
15.29
US$39,785
2,602 -1.5% 15.29 US$39,785
2023-11-22 2023-11-21 S Sale
26,691 -13.2%
14.84
US$396,094
26,691 -13.2% 14.84 US$396,094
2023-11-21 2023-11-21 PrS Proposed sale
29,293
14.88
US$435,957
29,293 14.88 US$435,957
2021-10-15 2021-10-14 PlS Planned sale
351 -0.7%
31.17
US$10,941
351 -0.7% 31.17 US$10,941
2021-10-15 2021-10-14 PlS Planned sale
4,649 -8.1%
30.42
US$141,423
4,649 -8.1% 30.42 US$141,423
2021-09-29 2021-09-27 PlS Planned sale
1,085 -2.0%
30.07
US$32,626
1,085 -2.0% 30.07 US$32,626